Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Prescription | 005 |
Prescription | 006 |
Prescription | 007 |
Application Products
001 | CAPSULE, EXTENDED RELEASE;ORAL | 10MG | 1 | APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE |
002 | CAPSULE, EXTENDED RELEASE;ORAL | 15MG | 1 | APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE |
003 | CAPSULE, EXTENDED RELEASE;ORAL | 20MG | 1 | APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE |
004 | CAPSULE, EXTENDED RELEASE;ORAL | 30MG | 1 | APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE |
005 | CAPSULE, EXTENDED RELEASE;ORAL | 40MG | 1 | APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE |
006 | CAPSULE, EXTENDED RELEASE;ORAL | 50MG | 1 | APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE |
007 | CAPSULE, EXTENDED RELEASE;ORAL | 60MG | 1 | APTENSIO XR | METHYLPHENIDATE HYDROCHLORIDE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2015-04-17 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 2015-09-15 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2017-01-04 | 901 REQUIRED |
EFFICACY; Efficacy | SUPPL | 5 | AP | 2019-06-14 | PRIORITY |
LABELING; Labeling | SUPPL | 6 | AP | 2021-06-25 | 901 REQUIRED |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 0 |
SUPPL | 3 | Null | 15 |
SUPPL | 5 | Null | 31 |
SUPPL | 6 | Null | 15 |
TE Codes
001 | Prescription | AB3 |
002 | Prescription | AB3 |
003 | Prescription | AB3 |
004 | Prescription | AB3 |
005 | Prescription | AB3 |
006 | Prescription | AB3 |
007 | Prescription | AB3 |
CDER Filings
RHODES PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 205831
[companyName] => RHODES PHARMS
[docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/205831s005lbl.pdf#page=22"]
[products] => [{"drugName":"APTENSIO XR","activeIngredients":"METHYLPHENIDATE HYDROCHLORIDE","strength":"10MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"APTENSIO XR","activeIngredients":"METHYLPHENIDATE HYDROCHLORIDE","strength":"15MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"APTENSIO XR","activeIngredients":"METHYLPHENIDATE HYDROCHLORIDE","strength":"20MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"APTENSIO XR","activeIngredients":"METHYLPHENIDATE HYDROCHLORIDE","strength":"30MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"APTENSIO XR","activeIngredients":"METHYLPHENIDATE HYDROCHLORIDE","strength":"40MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"APTENSIO XR","activeIngredients":"METHYLPHENIDATE HYDROCHLORIDE","strength":"50MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"APTENSIO XR","activeIngredients":"METHYLPHENIDATE HYDROCHLORIDE","strength":"60MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"06\/14\/2019","submission":"SUPPL-5","supplementCategories":"Efficacy","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/205831s005lbl.pdf\"}]","notes":""},{"actionDate":"01\/04\/2017","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/205831s003lbl.pdf\"}]","notes":""},{"actionDate":"04\/17\/2015","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/205831s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"04\/17\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2015\\\/205831s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2015\\\/205831Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2015\\\/205831Orig1s000TOC.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2015\\\/205831Orig1s000SumR.pdf\"}]","notes":">"}]
[supplements] => [{"actionDate":"06\/14\/2019","submission":"SUPPL-5","supplementCategories":"Efficacy","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/205831s005lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/205831Orig1s005ltr.pdf\"}]","notes":">"},{"actionDate":"01\/04\/2017","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/205831s003lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/205831Orig1s003ltr.pdf\"}]","notes":">"},{"actionDate":"09\/15\/2015","submission":"SUPPL-2","supplementCategories":"Manufacturing (CMC)","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2019-06-14
)
)